|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | -99.00% |
|
-.--% | -.--% |
| Mar. 22 | Disclosure Statement and Plan Approved on Interim Basis for Pear Therapeutics, Inc. | CI |
| Mar. 04 | Combined Liquidation Plan and Disclosure Statement Filed by Pear Therapeutics, Inc. | CI |
The US Bankruptcy Court approved on interim basis the disclosure statement of Pear Therapeutics, Inc. on March 22, 2024. The debtor had filed its disclosure statement in the Court on March 4, 2024. March 18, 2024 has been fixed as voting record date.
The deadline to vote on the plan, and the plan objection deadline is April 29, 2024. The confirmation hearing for the plan has been scheduled for May 6, 2024.
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 142 | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
PEAR THERAPEUTICS, INC. 
